Off a four-lane commercial strip dotted with chain restaurants in Westmoreland County, past grassy fields, is a squat building where some of the world’s most sophisticated scientific gear is made.
Export-based E.A. Fischione Instruments Inc. makes accessories that are used with powerful microscopes in more than 500 labs worldwide. Fischione is also growing — undergoing an expansion at its plant 25 miles east of Pittsburgh that will double its size to 51,000 square feet, thanks to a shift in focus that happened about the time of the stock market collapse in 2008.
“We knew there would be a significant economic downturn,” said CEO Paul Fischione, 59. “The question was: who would have the resources and funding that were not related to the economic conditions?”
Answering that question helped Fischione double its revenue and more than double its workforce between 2009 and 2011 in a niche, $3 billion worldwide market where several years can separate the start of marketing and the sale of a new product.
Fischione is privately held and does not disclose its financials, but the company anticipates doubling revenue and the number of employees again “in the foreseeable future,” Mr. Fischione said. The company employs 75 people.
The resourcefulness that Fischione showed in adapting to the 2008 downturn were qualities baked into the formation of the company in 1966 in the garage of Paul Fischione’s father.
Eugene Fischione, now 95, was a research machinist at U.S. Steel and involved in many of the early developments in the use of the electron microscope. Transmission electron microscopes use a beam of electrons to pierce ultra-thin specimens of ceramics or steel, creating a resolution that is 10,000 times sharper than a conventional microscope with glass lens.
Electron microscopes are used to see the structural properties of a wide variety of materials, including bits of tissue, rock formations and metals such as steel. The senior Fischione recognized an emerging market for devices that would aid in the use of these high-power microscopes.
Microscopic examinations make it possible to assess the durability of an implantable medical device made of metal, for example, or to assess metal fatigue that is sometimes seen in aircraft parts after years of use.
Among Eugene Fischione’s inventions was a way to create an electro-chemical reaction to prepare a specimen for viewing under an electron microscope. The company says the device is still used in more than 40 countries.
Paul Fischione’s acquisition of the company in 1986 from his father marked a new direction. The son graduated with a mechanical engineering degree from the University of Pittsburgh in 1978 and gained experience in the field by working in the engineering departments at Mine Safety Appliances Co., now based in Cranberry Township and United Technologies Corp. which has corporate headquarters in Hartford, Conn.
At the helm of the family business, Mr. Fischione expanded the product line. One innovation in the mid-1990s was a plasma cleaning technology, which is used to remove contaminants from specimens. A nano mill, which uses a concentrated argon ion beam, was introduced in 2004.
Later, Fischione introduced products for the semiconductor industry and large-scale imaging of geological samples. Analyzing geological samples for porosity allowed predictions to be made about the amount of oil or natural gas that a particular formation contained, saving energy companies time and exploration costs.
A lesson from the crash of 2008
The crash of 2008 forced Fischione to reconsider its business plan. Mr. Fischione said he remembers watching the news when investment banking giant Lehman Brothers filed for bankruptcy in September 2008 under the staggering weight of $619 billion in debt.
His first thought: It was critical to develop new markets because Fischione’s traditional clients in metals, semiconductors and energy were going to be cutting capital expenditures.
Adding life science applications was the answer, Mr. Fischione believed.
But first, he had to overcome employee apprehension.
“They thought I was crazy,” he said. “Basically, we targeted the basic science laboratories of the Department of Energy.”
Budgeting at big research institutions and federally funded labs was done years in advance, so they were largely immune to market gyrations. Serving the life sciences industry meant creating a new supply chain, training modules and documentation, but the effort paid off, Mr. Fischione said.
Today the company has a footprint in different industries, diversifying revenue in ways that help protect against downturns in one sector or another. “A very significant part of our business is international,” he said.
Life sciences products expand
Expanding into life sciences meant offering products that aided in visualizing flash-frozen specimens, which are usually prepared with super cold liquid nitrogen. Cryo-electron microscopy gives scientists subatomic views of cell architecture, viruses and proteins that are key to new drug research.
“Genetic information can lead to drug target development and clinically successful drugs,” said David Ledbetter, chief scientific officer at Danville, Pa.-based Geisinger Health System.
The latest cancer medications, for example, are tailored to the individual genetic mutations of the patient, so visualizing the binding of a small molecule drug to a key protein in a cancer cell can determine whether a medication will be effective.
Drug development often involves mapping small molecules and the binding sites of specific proteins.
“That’s exactly where we are now,” Mr. Fischione said. “We’re at the very edge of science and technology.”
Kris B. Mamula: kmamula@post-gazette.com or 412-263-1699.







Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.